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Abstract: 
The  Mycobacterium tuberculosis Proteome Comparison Database (MTB-PCDB) is an online database providing integrated access to proteome sequence 
comparison data for five strains of Mycobacterium tuberculosis (H37Rv, H37Ra, CDC 1551, F11 and KZN 1435) sequenced completely so far. MTB-PCDB 
currently hosts 40252 protein sequence comparison data obtained through inter-strain proteome comparison of five different strains of MTB. 2373 proteins were 
found to be identical in all 5 strains using MTB H37Rv as reference strain. To enable wide use of this data, MTB-PCDB provides a set of tools for searching, 
browsing, analyzing and downloading the data. By bringing together, M. tuberculosis proteome comparison among virulent & avirulent strains and also drug 
susceptible & drug resistance strains MTB-PCDB provides a unique discovery platform for comparative proteomics among these strains which may give insights 
into the discovery & development of TB drugs, vaccines and biomarkers. 
 
 
Availability: The database is available for free at http://www.bicjbtdrc-mgims.in/MTB-PCDB/ 
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Background: 
One third of the world’s population is considered to be infected with 
Mycobacterium tuberculosis, which leads to nearly 9.4 million new patients 
and 3 million deaths every year [1]. Multi-drug-resistant strains of this 
pathogen, emerging in association with HIV, have added a frightening 
dimension to the problem [2]. Outbreaks of extensively drug-resistant (XDR) 
tuberculosis have also been an increasing threat in certain regions around the 
world  [3]. As M. tb H37Rv is virulent and susceptible to most of the 
antitubercular drugs used so far, H37Ra which is an avirulent strain [4], and M. 
tb KZN strain is resistant to different drugs like isoniazid, rifampicin, 
kanamycin, ofloxacin, ethambutol, pyrazinamide etc. [5], there must be some 
genetic or proteomic mutations present in them. So, there is a need for genomic 
as well as proteomic analysis among different strains of MTB to know the 
variation among them.  The complete genome sequences of four clinical strains 
of Mycobacterium tuberculosis (H37Rv, CDC 1551, F11 and KZN 1435) and 
one avirulent strain H37Ra is available. In this study we did proteomic 
comparison amongst these strains of MTB by using NCBI's standalone BLAST 
algorithm [6].  
 
Materials and Methodology: 
Data Collection:  
Whole proteome sequences of four clinical (H37Rv [7], CDC 1551 [7], F11 [8] 
and KZN 1435 [8]) and one avirulent (H37Ra) strains of Mycobacterium 
tuberculosis were taken from NCBI Entrez Genome database [8] whose 
complete genome sequences were available as follows: (1) Mycobacterium 
tuberculosis H 37Rv (GenBank version-AL123456.2, Proteins-3988). (2) 
Mycobacterium tuberculosis H 37Ra (GenBank version-CP000611.1, Proteins-
4034). (3) Mycobacterium tuberculosis CDC1551 (GenBank version-
AE000516.2, Proteins-4189). (4) Mycobacterium tuberculosis F11 (GenBank 
version-CP000717.1, Proteins-3941). (5) Mycobacterium tuberculosis KZN 
1435 (GenBank version-CP001658.1, Proteins-4059). 
 
Database Architecture & Design: 
 Standalone BLAST program from NCBI was also downloaded and configured 
for local system. The proteome sequence were formatted using formatdb 
program of standalone BLAST, followed by pairwise comparison (Local 
BLAST) among each strain using blastall program of standalone BLAST 
taking whole proteome at a time. Mycobacterium tuberculosis Proteome 
Comparison Database (MTB-PCDB) was developed using Microsoft SQL 
Server as the back end. The output of the BLAST result was then parsed and 
stored in MS SQL relational database tables using in-house developed PERL 
code. While parsing BLAST output results, percentage identities, positivities, 
number of gaps, identical residues, bits, bits score, e-value, query length, 
subject length, query sequence, subject sequence, consensus sequence etc of 
the first hit obtained were taken into consideration for each protein comparison.  
 
Data Access: 
The interfaces of MTB-PCDB are designed in a manner to help users in easy 
navigation and retrieval of information from database for analysis. The 
database interfaces include: Home, Statistics, Advanced Search, Advanced BIOINFORMATION  open access 
 
ISSN 0973-2063 (online) 0973-8894 (print)     
Bioinformation 6(3): 131-133 (2011)  132  © 2011 Biomedical Informatics
 
 
 
Comparison, Useful Links and Help. The database can be queried to obtain the 
proteome sequence comparison information in different ways through a user 
friendly web interface as follows (Figure 1). The user can search protein 
sequence comparison data between any two strain of MTB by giving desired 
identities and percentage similarity. ii) Advanced Search options like identity, 
similarity, query coverage, bits, bits score etc. are provided for searching more 
specific information regarding pair wise proteome comparison. iii) A dynamic 
result page appears after any search in which user can sort the comparison 
results by identities, similarities, query coverage, bits score, query length, 
subject length etc. iv) The user can restrict the number of items to be shown per 
page obtained in searched result. v) The user can also download sequence 
comparison data. vi) Each comparison also navigates to the details of 
comparison between the two sequences of respective strains i.e., Protein Name, 
Protein Length, Start, End, Strand, Accession No., Gene ID, Locus, etc along 
with whole alignment between the query and subject sequence besides  the 
consensus sequence showing the matches, mismatches and gaps present in the 
alignments between them. vii) There is also an advanced comparison page for 
comparing proteome of multiple strains at a time.  
 
 
Figure 1: MTB-PCDB snapshots (a) Search option; (b) Search result; (c) Details about each comparison pair; (d) Advanced comparison; (e) Advanced 
comparison results 
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Comparison with other Databases: 
Some freely available online databases also host MTB information such as 
Tuberculist [9]  which includes genomic, proteomic, drugs, transcriptomics, 
mutant, operon annotations data etc. and Tuberculosis Database (TBDB) [10] 
provides access to genomic and annotation data of 28 different M. tb strains 
and related bacteria, also provides access to comparative genomic and 
microarray analysis software. For proteome comparison there is a web-based 
tool named Procom [11] for finding a subset of proteins of interest by 
comparing proteomes of 32 different species. However it does not consider M. 
tb. species for comparison. The uniqueness of MTB-PCDB is the involvement 
of comparative proteomics of five M. tb. strains whose genomes are completely 
sequenced. MTB-PCDB compares proteome of selected strains and displays 
detail information about each comparison pair along with the complete pair 
wise alignment to find out the point mutations and the consensus sequence. 
This may helps users to identify mutations involved in drug resistance and 
pathogenicity. 
 
Utility:  
MTB-PCDB, a comprehensive database with total of 40252 protein sequence 
comparison data. The proteomic variation found in five M. tuberculosis strains 
may have vital role in each species. This comparative study may help 
understand the mechanism of pathogenesis and survival of M. tuberculosis 
within the host. This information also facilitates design of new antitubercular 
vaccines and therapeutic agents based on the identified virulence-associated 
mutations.  
 
Caveats: 
MTB-PCDB does not include comparison of all the strains of M. tb as they are 
not completely sequenced.  
Future Developments: 
As and when in future, new TB strains are sequenced and available in public 
databases, we shall attempt to update MTB-PCDB including newly proteome 
comparison data. We would continue working on analyzing and correlating the 
proteomic variation among different strains with their drug resistance, 
virulence and pathogenic properties.  
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